Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS England
1st Floor, Quarry House, Quarry Hill
Leeds
LS2 7UE
UK
Person cyswllt: Jennifer Tierney
E-bost: Jennifer.Tierney@england.nhs.uk
NUTS: UKE
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.england.nhs.uk//
Cyfeiriad proffil y prynwr: https://www.england.nhs.uk//
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins
Cyfeirnod: CM/PHS/23/5703
II.1.2) Prif god CPV
33651520
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 1 400 000 000.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Ydy
II.2) Disgrifiad
Rhif y Lot 1-7
II.2.1) Teitl
1-7
II.2.2) Cod(au) CPV ychwanegol
33651520
II.2.3) Man cyflawni
Cod NUTS:
UK
Prif safle neu fan cyflawni:
Framework intended for use by the NHS in England, Northern Ireland, Scotland. The agreement may also be used by private sector contractors and agents working on behalf of the above.
II.2.4) Disgrifiad o’r caffaeliad
This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
28/05/2024
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. <br/><br/>The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender. <br/><br/>The market engagement documents will be made available during March for unrestricted and full direct access, free of charge, at http://health.atamis.co.uk under project reference C228466.<br/><br/>Please be aware the NHSE principal address has changed to Wellington House 133-155 Waterloo Road London SE1 8UG
VI.5) Dyddiad anfon yr hysbysiad hwn
13/03/2024